← peptides typeshit

Drew Fallon argues GLP-1 drugs are still underrated despite all the attention

Fallon says semaglutide and tirzepatide pull in about 60% of the combined run rate revenue of Anthropic and OpenAI, at a sixth of the reach.

See it on X

Recap by typeshit. Post by Drew Fallon on X.